A New Look at Diabetic Neuropathy
Stephanie Eid, Ph.D., led a research team examining gene expression at two injury sites in peripheral neuropathy to identify new therapy targets, publishing their findings in Translational Research.
“Neuropathy develops clinically in a distal (nerves in the toes, for example) to proximal (nerves in the legs and thighs) manner,” explained Frances and Kenneth Eisenberg Emerging Scholar Stephanie Eid, Ph.D. This study found that this clinical presentation (distal-to-proximal) is associated with different gene expression signatures at different injury sites.”
When looking at gene expression profiles, they found that specific pathways related to the body’s defense system, inflammation, or how it processes sugar and fat were similarly disrupted at distal and proximal sites. However, some of these disruptions were unique to specific areas of nerve injury, demonstrating that nerve damage in peripheral neuropathy can vary depending on location. Together, these findings indicate that different nerve locations are associated with unique changes in gene expression, which will ultimately impact mechanism-based therapeutic interventions.
In This Story
Stéphanie Eid, PhD
Center Member
Featured News & Stories
Study reveals the dual role for a protein critical for healing nerve damage
Diabetic teens with high blood sugar have higher neuropathy risk in adulthood
Nerve damage reduced in prediabetic mice with diet, exercise
Work-related nerve injuries are common with repetitive motions
Neuropathy Research Covered by U.S. News and Many More